In contrast, we found that AML patients as a whole had a significantly higher CD8 Teff proportion than HDs, which suggested that leukemia cells existing in AML BM microenvironment might trigger a strong CD8 T-cell response and cause CD8 T cells differentiation to the effector phase. Here, CD8A is linked to acute myeloid leukemia.